Valo Therapeutics
PrivateLast Round
VC Round
Mar 10, 2025
Total Funding Raised
$24.37M
Company Overview
Valo Therapeutics is a biotechnology company that develops novel immunotherapies for cancer and infectious diseases using its proprietary PeptiCRAd platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Valo Therapeutics Comparables
Compare Valo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TILT Biotherapeutics | 89% | |
| Nouscom | 83% | |
| Accession Therapeutics Limited | 82% | |
Valo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 10, 2025 | ||||
| Grant | Feb 14, 2023 | ||||
| Private Equity | Nov 15, 2021 | ||||
| Seed | Feb 6, 2020 | ||||
| Debt | Jul 4, 2017 | ||||
Seed | Jan 1, 2017 |
Key People
Founding team and executive leadership
Valo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Freeman Road | VC Round |
| European Innovation Council Fund | Grant |
| Indaco Venture Partners SGR | VC Round |
| CDP Venture Capital SGR | VC Round |
| Tekes | Debt |
| ENEA-Tech and Biomedical Foundation | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 34% MoM, from 674 to 900.
- Apr 9, 2025
Marcella Origgi joins as the new CEO, coming from Johnson & Johnson Innovation.
Valo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Valo Therapeutics's valuation, stock price, and market status.